Results decent but shows the executive have not done a good job of setting guidance reasonably. Underlying growth in revenue is good, but just have to tighten a little on NPAT. Assuming the heat coming out of wages I would assume better cost control moving forward.
honestly pathology in this country is a bit of a cash cow. Management should be keeping it tight and getting ready for the next outbreak to manifest.
buying at this price, but a little side-eye at the board TBH.
cheers,
YS
- Forums
- ASX - By Stock
- Ann: 1H25 financial results investor presentation
ACL
australian clinical labs limited
Add to My Watchlist
0.53%
!
$2.82

Results decent but shows the executive have not done a good job...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.82 |
Change
-0.015(0.53%) |
Mkt cap ! $549.8M |
Open | High | Low | Value | Volume |
$2.83 | $2.83 | $2.78 | $1.158M | 414.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 13291 | $2.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.82 | 17864 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 11920 | 2.810 |
14 | 11332 | 2.800 |
21 | 20209 | 2.790 |
10 | 108703 | 2.780 |
12 | 100986 | 2.770 |
Price($) | Vol. | No. |
---|---|---|
2.820 | 24063 | 25 |
2.830 | 16725 | 18 |
2.840 | 14349 | 7 |
2.850 | 79108 | 8 |
2.860 | 11594 | 3 |
Last trade - 14.32pm 29/07/2025 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |